Scholarly article on COBALTION 22541-63-5 from Journal of the American Chemical Society p. 2454 - 2455

DOI: 10.1021/ja01567a027

Source and publish data:

Journal of the American Chemical Society p. 2454 - 2455 (1957)

Update date:2022-08-16

Topics:

Authors:

Jonassen, H. B.

Frey, F. W.

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1021/ja01567a027

Full text of DOI:10.1021/ja01567a027

Products guided by the article

Product name:COBALTION

Cas No:22541-63-5

R&D Labs maybe for 22541-63-5

ShenZhen InnoSyn Biotech Co.,Ltd

website:http://www.innosyns.com

Contact:+86-755-28351685

Address:Floor 5 & 6, Building A1, HAIKEXING Strategic Innovative Industrial Park, 16 BaoShan Road, PingShan District
Liao Cheng All Win Chemicals Co.,LTD

Contact:86+0635-2991582

Address:Room 402,Unit 1,No.27 building.Zhong tong shi dai haoyuan,liaocheng city,Shan dong Province.China
TIANJIN FESTO CHEMICAL CO.,LTD(expird)

Contact:86-22-25814570

Address:No.12th,5th Ave.,TEDA,Tianjin,China
Shandong Jusage Technology Co.,Ltd.

Contact:86-13406130167

Address:No.20,North Ride No.9 Road, Guangrao Economic Development Zone, Shandong Province
Anhui Xinyuan Technology Co.,Ltd

Contact:0086-559-3515800

Address:No.16 Zijin Rd, Circular Economic Zone, Huizhou District, Huangshan Anhui China

Relevant to this article

Ligand-induced reactivity of β-diketiminate magnesium complexes for regioselective functionalization of fluoroarenes: Via C-H or C-F bond activations

Doi:10.1039/c7cc07193k
(2017)
Enantioselective catalytic addition of allyl organometallic reagents to aldehydes promoted by [Cr(Salen)]: The hidden role played by weak Lewis acids in metallo-Salen promoted reactions

Doi:10.1016/S0040-4020(00)01047-4
(2001)
Doi:10.1039/c19670000759
(1967)
(1S,2R,8R,8aR)-1,2,8-Trihydroxyoctahydroindolizine (Swainsonine), an α-mannosidase inhibitor from Rhizoctonia leguminicola

Doi:10.1016/S0040-4020(01)97625-2
(1983)
Doi:10.1039/jr9510000824
(1951)
Optimization of a series of potent, selective and orally bioavailable SYK inhibitors

Doi:10.1016/j.bmcl.2020.127433
(2020)

Article Doi

DOI: 10.1021/ja01567a027